# A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea

> **NCT00578773** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 303 (actual)

## Conditions studied

- Acute Otitis Media

## Interventions

- **DRUG:** Moxidex otic solution
- **DRUG:** Moxifloxacin otic solution
- **DEVICE:** Tympanostomy tubes

## Key facts

- **NCT ID:** NCT00578773
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578773, "A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00578773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*